Skip to main content

Iloprost Inhalation Solution (Ventavis) Shortage

Last Updated: March 18, 2024
Status: Current

Products Affected - Description
    • Ventavis inhalation solution, Janssen, 10 mcg/mL, 1 mL ampule, 30 count, NDC 66215-0302-30
    • Ventavis inhalation solution, Janssen, 20 mcg/mL, 1 mL ampule, 30 count, NDC 66215-0303-30
Reason for the Shortage
    • Janssen does not have Ventavis available for use in the US for new patients due to the FDA-approved delivery system (I-neb AAD system) being discontinued by Philips Respironics.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Ventavis 10 mcg/mL 1 mL ampules and 20 mcg/mL 1 mL ampules are available for current patients.

Implications for Patient Care

    • Providers will need to work to switch patients to an alternative pulmonary hypertension treatment. New prior authorizations for alternative treatments will likely be required

Updated

Updated March 18, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 28, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.